136 related articles for article (PubMed ID: 33564742)
1. Effects of a 1-Year Physical Activity Intervention on Markers of Hemostasis among Breast Cancer Survivors: A Randomized Controlled Trial.
Bøhn SK; Thune I; Flote VG; Frydenberg H; Bertheussen GF; Husøy A; Fjeldheim F; Brunvoll SH; Hjartåker A; Mowinckel MC; Sandset PM; Iversen PO
TH Open; 2021 Jan; 5(1):e14-e23. PubMed ID: 33564742
[No Abstract] [Full Text] [Related]
2. Effects on hemostasis after two-year use of low dose combined oral contraceptives with gestodene or levonorgestrel.
Prasad RN; Koh SC; Viegas OA; Ratnam SS
Clin Appl Thromb Hemost; 1999 Jan; 5(1):60-70. PubMed ID: 10725985
[TBL] [Abstract][Full Text] [Related]
3. Short-term effects of estrogen, tamoxifen and raloxifene on hemostasis: a randomized-controlled study and review of the literature.
Cosman F; Baz-Hecht M; Cushman M; Vardy MD; Cruz JD; Nieves JW; Zion M; Lindsay R
Thromb Res; 2005; 116(1):1-13. PubMed ID: 15850603
[TBL] [Abstract][Full Text] [Related]
4. Double-blind, randomized, placebo controlled study on the effects of the monophasic oral contraceptive containing 30 micrograms ethinyl estradiol and 2.00 mg dienogest on the hemostatic system.
Spona J; Feichtinger W; Kindermann C; Schneider B; Mellinger U; Walter F; Moore C; Gräser T
Contraception; 1997 Aug; 56(2):67-75. PubMed ID: 9315414
[TBL] [Abstract][Full Text] [Related]
5. Hemostatic Markers and Long-Term Risk of Intracerebral Hemorrhage in Postmenopausal Women.
Lee JM; Siddique J; Kim HC; Green D; Van Horn L; Allison M; Wassertheil-Smoller S; Greenland P
J Stroke Cerebrovasc Dis; 2016 Jul; 25(7):1639-1643. PubMed ID: 27067884
[TBL] [Abstract][Full Text] [Related]
6. Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives.
Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Koster T; Bertina RM; Vandenbroucke JP
Thromb Haemost; 1998 Sep; 80(3):382-7. PubMed ID: 9759614
[TBL] [Abstract][Full Text] [Related]
7. Maternal and cord blood hemostasis at delivery.
Schneider DM; von Tempelhoff GF; Herrle B; Heilmann L
J Perinat Med; 1997; 25(1):55-61. PubMed ID: 9085204
[TBL] [Abstract][Full Text] [Related]
8. [Indirect comparison of changes of parameters of hemostasis during short-term use of ticlopidine and clopidogrel in patients with non-ST elevation acute coronary syndrome].
Slavina NN; Averkov OV; Gratsianskiĭ NA
Kardiologiia; 2005; 45(12):11-6. PubMed ID: 16353041
[TBL] [Abstract][Full Text] [Related]
9. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
Stephenson K; Neuenschwander PF; Kurdowska AK
Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
[TBL] [Abstract][Full Text] [Related]
10. Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial.
Scarabin PY; Alhenc-Gelas M; Plu-Bureau G; Taisne P; Agher R; Aiach M
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3071-8. PubMed ID: 9409295
[TBL] [Abstract][Full Text] [Related]
11. Socioeconomic status and determinants of hemostatic function in healthy women.
Wamala SP; Murray MA; Horsten M; Eriksson M; Schenck-Gustafsson K; Hamsten A; Silveira A; Orth-Gomér K
Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):485-92. PubMed ID: 10073947
[TBL] [Abstract][Full Text] [Related]
12. Tissue factor pathway inhibitor and other endothelium-dependent hemostatic factors in elderly individuals with normal or impaired glucose tolerance and type 2 diabetes.
Leurs PB; Stolk RP; Hamulyak K; Van Oerle R; Grobbee DE; Wolffenbuttel BH
Diabetes Care; 2002 Aug; 25(8):1340-5. PubMed ID: 12145232
[TBL] [Abstract][Full Text] [Related]
13. Dietary soy containing phytoestrogens does not activate the hemostatic system in postmenopausal women.
Teede HJ; Dalais FS; Kotsopoulos D; McGrath BP; Malan E; Gan TE; Peverill RE
J Clin Endocrinol Metab; 2005 Apr; 90(4):1936-41. PubMed ID: 15657372
[TBL] [Abstract][Full Text] [Related]
14. Inverse correlation between thyroid function and hemostatic markers for coronary heart disease in obese children and adolescents.
Gallistl S; Sudi KM; Leschnik B; Muntean W; Borkenstein MH
J Pediatr Endocrinol Metab; 2000; 13(9):1615-20. PubMed ID: 11154157
[TBL] [Abstract][Full Text] [Related]
15. Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study.
Meigs JB; Mittleman MA; Nathan DM; Tofler GH; Singer DE; Murphy-Sheehy PM; Lipinska I; D'Agostino RB; Wilson PW
JAMA; 2000 Jan; 283(2):221-8. PubMed ID: 10634338
[TBL] [Abstract][Full Text] [Related]
16. Oral conjugated equine estrogen increases plasma von Willebrand factor in postmenopausal women.
Rabbani LE; Seminario NA; Sciacca RR; Chen HJ; Giardina EG
J Am Coll Cardiol; 2002 Dec; 40(11):1991-9. PubMed ID: 12475460
[TBL] [Abstract][Full Text] [Related]
17. Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment.
Lip GY; Lowe GD; Rumley A; Dunn FG
Br Heart J; 1995 Jun; 73(6):527-33. PubMed ID: 7626351
[TBL] [Abstract][Full Text] [Related]
18. Association of anthropometric measures and hemostatic factors in postmenopausal women: a longitudinal study.
Kabat GC; Heo M; Allison MA; Hou L; Nassir R; Zaslavsky O; Rohan TE
Nutr Metab Cardiovasc Dis; 2014 Oct; 24(10):1120-7. PubMed ID: 24880739
[TBL] [Abstract][Full Text] [Related]
19. Hypercoagulability in patients with chronic noncirrhotic portal vein thrombosis.
Raffa S; Reverter JC; Seijo S; Tassies D; Abraldes JG; Bosch J; García-Pagán JC
Clin Gastroenterol Hepatol; 2012 Jan; 10(1):72-8. PubMed ID: 21946303
[TBL] [Abstract][Full Text] [Related]
20. Transdermal estrogen replacement therapy: beneficial effects on hemostatic risk factors for cardiovascular disease.
Lindoff C; Peterson F; Lecander I; Martinsson G; Astedt B
Maturitas; 1996 May; 24(1-2):43-50. PubMed ID: 8794433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
